InvestorsHub Logo

Lemoncat

01/03/19 3:34 PM

#253324 RE: scottsmith #253321

Preclinical combo tests were performed at Beth Israel using Kevetrin and a Pfizer drug. It says nothing about Pfizer's involvement.

Furthermore, thise tests were wildly successful as noted in this PR:

http://m.marketwired.com/press-release/cellceutixs-clinical-trial-anti-cancer-agent-kevetrin-meeting-its-goals-approaching-otc-ctix-2049208.htm

Again, we will make a gigantic deal on Kevetrin after we perfect the oral formulation. We want to unlock more easy value before partnering.